NEW YORK, Dec. 12 – Celera Genomics and Syrrx said Wednesday they had formed a drug discovery research collaboration.

Structural genomics company Syrrx said it would use its technology for determining a protein’s structure to uncover the 3-D make-up of proteins Celera identifies as potential drug targets.

Celera said it would use the information generated through the collaboration to discover small molecule drugs. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.